{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:22Z","timestamp":1793293882228,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers K.K."},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tanabe Mitsubishi Pharma"},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"name":"Taisho-Toyama"},{"name":"Janssen"},{"DOI":"10.13039\/100014421","name":"EA Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ayumi Pharmaseutical"},{"name":"Takeda Pharmaceutical"},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen Pharmaceutical K.K."},{"name":"Asahi Kasei Pharma"},{"name":"AstraZeneca K.K."},{"name":"Eli Lilly Japan K.K."},{"DOI":"10.13039\/100008792","name":"Novartis Pharma K.K.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10067-017-3854-8","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T01:18:37Z","timestamp":1506993517000},"page":"765-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Maho","family":"Nakazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"3854_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"3854_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","volume":"28","author":"IJ Chen","year":"2009","unstructured":"Chen IJ, Jan Wu YJ, Lin CW, Fan KW, Leu SF, Ho HH et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28:639\u2013646","journal-title":"Clin Rheumatol"},{"key":"3854_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","volume":"39","author":"H Yoshifuji","year":"2006","unstructured":"Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D et al (2006) Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39:233\u2013241","journal-title":"Autoimmunity"},{"key":"3854_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/keu166","volume":"54","author":"T Kurita","year":"2015","unstructured":"Kurita T, Yasuda S, Oba K, Odani T, Kono M, Otomo K et al (2015) The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. Rheumatology (Oxford) 54:39\u201344","journal-title":"Rheumatology (Oxford)"},{"key":"3854_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626\u2013636","journal-title":"J Am Acad Dermatol"},{"key":"3854_CR6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/1529-0131(199809)41:9<1625::AID-ART13>3.0.CO;2-D","volume":"41","author":"Y Ohosone","year":"1998","unstructured":"Ohosone Y, Ishida M, Takahashi Y, Matsumura M, Hirakata M, Kawahara Y et al (1998) Spectrum and clinical significance of autoantibodies against transfer RNA. Arthritis Rheum 41:1625\u20131631","journal-title":"Arthritis Rheum"},{"key":"3854_CR7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636\u2013643","journal-title":"Am J Respir Crit Care Med"},{"key":"3854_CR8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788\u2013824","journal-title":"Am J Respir Crit Care Med"},{"key":"3854_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3854_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098824","volume":"9","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9(6):e98824","journal-title":"PLoS One"},{"key":"3854_CR11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS et al (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156:684\u2013691","journal-title":"Ann Intern Med"},{"key":"3854_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08916930500124023","volume":"38","author":"K Takada","year":"2005","unstructured":"Takada K, Nagasaka K, Miyasaka N (2005) Polymyositis\/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 38:383\u2013392","journal-title":"Autoimmunity"},{"key":"3854_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","volume":"32","author":"A Schnabel","year":"2003","unstructured":"Schnabel A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32:273\u2013284","journal-title":"Semin Arthritis Rheum"},{"key":"3854_CR14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164:1182\u20131185","journal-title":"Am J Respir Crit Care Med"},{"key":"3854_CR15","first-page":"58","volume":"32","author":"T Fujisawa","year":"2005","unstructured":"Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M et al (2005) Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 32:58\u201364","journal-title":"J Rheumatol"},{"key":"3854_CR16","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1183\/09031936.97.10122907","volume":"10","author":"A Sauty","year":"1997","unstructured":"Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM et al (1997) Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 10:2907\u20132912","journal-title":"Eur Respir J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3854-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:59:15Z","timestamp":1589777955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3854-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3854"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3854-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}